2013 Korean Society of Hypertension guidelines for the management of hypertension. Part II-treatments of hypertension

Clinical Hypertension
Jinho ShinGuideline Committee of the Korean Society of Hypertension

Abstract

Treatment strategies are provided in accordance with the level of global cardiovascular risk, from lifestyle modification in the lower risk group to more comprehensive treatment in the higher risk group. Considering the common trend of combination drug regimen, the choice of the first drug is suggested more liberally according to the physician's discretion.

References

Dec 1, 1989·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·A ZanchettiP Sleight
Oct 8, 1994·BMJ : British Medical Journal·R DollI Sutherland
May 13, 1998·Circulation·N J Brown, D E Vaughan
Jul 14, 2001·The American Journal of Clinical Nutrition·E ObarzanekUNKNOWN DASH Research Group
Nov 21, 2002·JAMA : the Journal of the American Medical Association·Jackson T WrightUNKNOWN African American Study of Kidney Disease and Hypertension Study Group
Sep 19, 2003·Lancet·K M Fox, UNKNOWN EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators
Oct 25, 2003·Stroke; a Journal of Cerebral Circulation·Parveen RashidPhilip Bath
Nov 12, 2003·Hypertension·Feng J He, Graham A MacGregor
Dec 6, 2003·Hypertension·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Aug 6, 2004·The New England Journal of Medicine·Biff F Palmer
Sep 8, 2004·Lancet·Philip A Poole-WilsonUNKNOWN Coronary disease Trial Investigating Outcome with Nifedipine gastrointestinal therapeutic system investigators
Nov 9, 2004·The New England Journal of Medicine·Eugene BraunwaldUNKNOWN PEACE Trial Investigators
Nov 13, 2004·JAMA : the Journal of the American Medical Association·George L BakrisUNKNOWN GEMINI Investigators
Dec 28, 2004·The American Journal of Cardiology·Franz H MesserliCarl J Pepine
Mar 16, 2006·The New England Journal of Medicine·Stevo JuliusUNKNOWN Trial of Preventing Hypertension (TROPHY) Study Investigators
Apr 6, 2006·Annals of Internal Medicine·Patricia J ElmerUNKNOWN PREMIER Collaborative Research Group
May 11, 2006·Journal of Hypertension·Hisatomi ArimaUNKNOWN PROGRESS Collaborative Group
Aug 11, 2006·The New England Journal of Medicine·Pierre AmarencoUNKNOWN Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators
Aug 24, 2006·The New England Journal of Medicine·Sun Ha JeeJonathan M Samet
Mar 14, 2007·Journal of Hypertension·Faiez Zannad
Apr 2, 2008·The New England Journal of Medicine·Nigel S BeckettUNKNOWN HYVET Study Group
Apr 2, 2008·The New England Journal of Medicine·UNKNOWN ONTARGET InvestigatorsCraig Anderson
Aug 30, 2008·The New England Journal of Medicine·Salim YusufUNKNOWN PRoFESS Study Group
Nov 11, 2008·The New England Journal of Medicine·Paul M RidkerUNKNOWN JUPITER Study Group
Dec 5, 2008·The New England Journal of Medicine·Kenneth JamersonUNKNOWN ACCOMPLISH Trial Investigators
Jan 14, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·UNKNOWN JATOS Study Group

❮ Previous
Next ❯

Citations

Feb 17, 2018·The Journal of Clinical Hypertension·Kazuomi KarioJi-Guang Wang
Nov 25, 2017·Korean Circulation Journal·Jae Hyeong Park, Jae Hwan Lee
Aug 2, 2019·The Journal of Clinical Hypertension·Tomasz MiazgowskiBartosz Miazgowski
Oct 20, 2019·The Journal of Clinical Hypertension·Sungha Park, Jinho Shin
Mar 4, 2018·Heart·Fu Liang Ng, Melvin David Lobo
Oct 11, 2016·Korean Circulation Journal·Jang Young Kim
Apr 14, 2020·Korean Circulation Journal·Jinho Shin, Myeong Chan Cho
Feb 27, 2019·Korean Circulation Journal·Hokyou LeeHyeon Chang Kim
Sep 19, 2019·The Journal of Clinical Hypertension·Kazuomi KarioJi-Guang Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Das Deutsche Gesundheitswesen
S KREFFT
Revue médicale suisse
B Hoerni
Deutsche medizinische Wochenschrift
W Barnikel
Deutsche Zeitschrift für die gesamte gerichtliche Medizin
E Trube-Becker
© 2022 Meta ULC. All rights reserved